Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy for Recurrent Head and Neck Cancer
NCT02549742Phase 2Unknown
- Sponsor
- Rigshospitalet
- Start
- Feb 2014
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin in head and neck cancer (HNC), sponsored by Rigshospitalet. Status: unknown.
02
Drugs
bleomycin
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT02549742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549742.